boceprevir,masitinibrupintrivirSARS-CoV-2;

Mehdi Yoosefian1,2, Razieh Dashti2, Mohamad Mahani1

  • 1Department of Chemistry, Graduate University of Advanced Technology, Kerman, Iran.

Arabian journal of chemistry
|June 16, 2023
PubMed
概括

研究人员研究了针对SARS-CoV-2主要蛋白酶的潜在抗病毒药物. 对接研究显示boceprevir,masitinib和rupintrivir具有有利的结合能量和相互作用,证实了COVID-19药物发现的复杂稳定性.